BOSS ZHIPIN-W(02076): The trustee purchased 370,900 shares of Class A common stock based on the initial public offering.
BOSS Zhipin-W (02076) issued an announcement on November 14, 2024, allocating internal resources by the company...
BOSS ZHIPIN-W (02076) issued an announcement on November 14, 2024, stating that the company's internal resources were used to purchase a total of 370,900 shares of Class A common stock (in the form of 185,400 American Depositary Shares) in the open market for the first public offering trustee under the terms and conditions of the plan, and to hold these shares in trust for eligible participants.
Related Articles
.png)
IPO news | Keen Gene submits application to Hong Kong Stock Exchange

JACOBIO-B(01167) subsidiary enters into licensing and collaboration agreement with AstraZeneca to develop and commercialize the pan-KRAS inhibitor JAB-23E73.

China Securities Co., Ltd.: Three clues for A-share investment at the end of the year and the beginning of the year.
IPO news | Keen Gene submits application to Hong Kong Stock Exchange
.png)
JACOBIO-B(01167) subsidiary enters into licensing and collaboration agreement with AstraZeneca to develop and commercialize the pan-KRAS inhibitor JAB-23E73.

China Securities Co., Ltd.: Three clues for A-share investment at the end of the year and the beginning of the year.






